| Synonyms | PF-06685360 |
|---|
| CAS No. | 1527475-61-1 |
|---|
| Purity | >98% |
|---|
| Formula | C16H16N6O |
|---|
| Mol Weight | 308.3378 |
|---|
| State | solid powder |
|---|
| Solubility | Soluble in DMSO, not in water |
|---|
| Shelf Life | >2 years if stored properly |
|---|
| Storage | Powder -20℃ 3 years; In solvent -20℃ 1 month; |
|---|
| Shipping | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
|---|
| |
|---|
| | |
|---|
| Reference: | [1]. Marco A.S. Baptista, et al. LRRK2 Kinase Inhibitors of Different Structural Classes Induce Abnormal Accumulation of Lamellar Bodies in Type II Pneumocytes in Non-Human Primates but are Reversible and Without Pulmonary Functional Consequences.
[2]. Andersen MA, et al. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation. Neurobiol Dis. 2018 Aug;116:13-27.
[3]. Andersen MA, et al. PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats. Toxicology. 2018 Feb 15;395:15-22. |
|---|
| CoA | CoA of PFE-360 |
|---|
Inhibitor Specialist 
